Kenvue Inc. $KVUE Stock Holdings Increased by Carmignac Gestion

Carmignac Gestion raised its position in shares of Kenvue Inc. (NYSE:KVUE – Free Report) by 166.8% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 420,432 shares of the company’s stock after buying an additional 262,858 shares during the quarter. Carmignac Gestion’s holdings in Kenvue were worth $8,034,000 at the end of the most recent quarter.

Bullseye Bounce: Toms Capital Takes a Stake in Target

Other large investors also recently bought and sold shares of the company. Elyxium Wealth LLC acquired a new position in Kenvue in the fourth quarter worth $26,000. Johnson Financial Group Inc. acquired a new stake in shares of Kenvue during the second quarter worth $26,000. MV Capital Management Inc. acquired a new stake in shares of Kenvue during the fourth quarter worth $28,000. CoreCap Advisors LLC lifted its position in shares of Kenvue by 64.9% in the 2nd quarter. CoreCap Advisors LLC now owns 1,502 shares of the company’s stock worth $29,000 after buying an additional 591 shares during the last quarter. Finally, Reflection Asset Management bought a new position in shares of Kenvue in the 4th quarter worth about $32,000. Institutional investors own 97.64% of the company’s stock.

Kenvue Stock Performance

NYSE:KVUE traded down $0.35 during mid-day trading on Tuesday, hitting $18.39. The stock had a trading volume of 16,219,959 shares, compared to its average volume of 27,713,732. The company has a current ratio of 1.01, a quick ratio of 0.71 and a debt-to-equity ratio of 0.67. The company has a 50 day simple moving average of $19.18 and a 200-day simple moving average of $18.26. The stock has a market capitalization of $35.31 billion, a price-to-earnings ratio of 21.13, a P/E/G ratio of 1.67 and a beta of 0.46. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $20.13.

Insider Buying: Smart Money Just Spent +$100M on These 3 Stocks

Kenvue (NYSE:KVUE – Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $0.31 EPS for the quarter, missing the consensus estimate of $0.32 by ($0.01). Kenvue had a return on equity of 21.22% and a net margin of 10.76%.The firm had revenue of $3.96 billion during the quarter, compared to the consensus estimate of $3.97 billion. During the same quarter last year, the company posted $0.29 EPS. Kenvue’s revenue for the quarter was up 3.0% on a year-over-year basis. On average, research analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, August 26th. Investors of record on Wednesday, August 12th were issued a $0.21 dividend. This is a positive change from Kenvue’s previous quarterly dividend of $0.21. The ex-dividend date of this dividend was Wednesday, August 12th. This represents a $0.84 dividend on an annualized basis and a yield of 4.6%. Kenvue’s dividend payout ratio is currently 96.55%.

Analyst Upgrades and Downgrades

3 Smart Defensive Stocks for an Uneasy Market

A number of brokerages recently weighed in on KVUE. Zacks Research downgraded shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 7th. Weiss Ratings raised shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, June 15th. Wall Street Zen downgraded Kenvue from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. UBS Group lowered their target price on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a report on Tuesday, August 11th. Finally, Barclays increased their price target on Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 21st. Three investment analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $19.27.

Read Our Latest Stock Analysis on Kenvue

About Kenvue

(Free Report)

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

Should You Invest $1,000 in Kenvue Right Now?

Before you consider Kenvue, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Kenvue wasn’t on the list.

While Kenvue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report